Ryman Healthcare Limited (NZE:RYM)
New Zealand
· Delayed Price · Currency is NZD 2.290
+0.040 (1.78%)
Mar 10, 2026, 11:49 AM NZST
Ryman Healthcare Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,283 | 2,799 | 3,117 | 3,598 | 4,665 | 7,609 | Upgrade
|
| Market Cap Growth | -24.87% | -10.22% | -13.35% | -22.88% | -38.69% | 48.41% | Upgrade
|
| Enterprise Value | 3,970 | 5,409 | 5,605 | 6,623 | 7,122 | 9,759 | Upgrade
|
| Last Close Price | 2.25 | 2.76 | 4.21 | 4.86 | 7.96 | 12.75 | Upgrade
|
| PE Ratio | - | - | - | 13.95 | 6.73 | 17.98 | Upgrade
|
| Forward PE | 16.50 | 12.14 | 11.17 | 10.18 | 16.49 | 26.37 | Upgrade
|
| PS Ratio | 2.83 | 3.69 | 4.53 | 6.19 | 9.17 | 16.70 | Upgrade
|
| PB Ratio | 0.55 | 0.66 | 0.83 | 0.77 | 1.36 | 2.69 | Upgrade
|
| P/TBV Ratio | 0.55 | 0.66 | 0.84 | 0.79 | 1.38 | 2.73 | Upgrade
|
| P/FCF Ratio | 8.72 | 10.99 | 9.27 | 16.43 | 18.54 | 48.61 | Upgrade
|
| P/OCF Ratio | 7.09 | 6.82 | 5.24 | 5.61 | 7.96 | 18.42 | Upgrade
|
| PEG Ratio | - | - | - | - | 6.97 | 2.25 | Upgrade
|
| EV/Sales Ratio | 4.92 | 7.13 | 8.15 | 11.39 | 14.00 | 21.42 | Upgrade
|
| EV/EBITDA Ratio | 91.74 | - | - | 272.11 | 205.02 | 184.93 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 3810.78 | 1044.34 | 348.33 | Upgrade
|
| EV/FCF Ratio | 15.17 | 21.24 | 16.66 | 30.24 | 28.30 | 62.35 | Upgrade
|
| Debt / Equity Ratio | 0.41 | 0.40 | 0.69 | 0.50 | 0.76 | 0.82 | Upgrade
|
| Debt / EBITDA Ratio | 39.20 | - | - | 84.83 | 69.96 | 41.93 | Upgrade
|
| Debt / FCF Ratio | 6.48 | 6.72 | 7.67 | 10.73 | 10.40 | 14.80 | Upgrade
|
| Net Debt / Equity Ratio | 0.41 | 0.40 | 0.67 | 0.49 | 0.75 | 0.81 | Upgrade
|
| Net Debt / EBITDA Ratio | 42.82 | -313.43 | -65.11 | 93.94 | 73.97 | 43.52 | Upgrade
|
| Net Debt / FCF Ratio | 6.45 | 6.64 | 7.50 | 10.44 | 10.21 | 14.67 | Upgrade
|
| Asset Turnover | 0.07 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Inventory Turnover | 799.38 | 626.17 | 83.74 | 26.49 | 17.58 | - | Upgrade
|
| Quick Ratio | 0.01 | 0.01 | 0.02 | 0.14 | 0.69 | 0.78 | Upgrade
|
| Current Ratio | 0.03 | 0.04 | 0.06 | 0.15 | 0.73 | 0.83 | Upgrade
|
| Return on Equity (ROE) | -13.37% | -10.91% | -4.04% | 6.37% | 22.12% | 16.49% | Upgrade
|
| Return on Assets (ROA) | 0.04% | -0.21% | -0.36% | 0.01% | 0.04% | 0.21% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.13% | -0.66% | -1.06% | 0.03% | 0.12% | 0.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.10% | -0.70% | -1.10% | 0.00% | 0.10% | 0.30% | Upgrade
|
| Earnings Yield | -24.70% | -15.61% | -5.44% | 7.17% | 14.85% | 5.56% | Upgrade
|
| FCF Yield | 11.46% | 9.10% | 10.79% | 6.09% | 5.39% | 2.06% | Upgrade
|
| Dividend Yield | - | - | - | 1.81% | 2.81% | 1.76% | Upgrade
|
| Payout Ratio | - | - | - | 26.41% | 16.16% | 25.41% | Upgrade
|
| Buyback Yield / Dilution | -27.13% | -3.28% | -33.18% | -3.26% | - | - | Upgrade
|
| Total Shareholder Return | -27.13% | -3.28% | -33.18% | -1.45% | 2.81% | 1.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.